ALGS

$0.00

(

0.00%

)
Quote details

stock

Aligos Therapeutics Inc

NASDAQ | ALGS

12.00

USD

$0.00

(

0.00%

)

At Close (As of Dec 15, 2025)

$73.84M

Market Cap

-

P/E Ratio

-13.54

EPS

$46.80

52 Week High

$3.76

52 Week Low

HEALTHCARE

Sector

ALGS Chart

Recent Chart
Price Action

ALGS Technicals

Tags:

ALGS Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $70M
Total Current Assets $62M
Cash And Cash Equivalents At Carrying Value $37M
Cash And Short Term Investments $37M
Inventory -
Current Net Receivables -
Total Non Current Assets $8M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $20M
Other Current Assets $5.2M
Other Non Current Assets -
Total Liabilities $99M
Total Current Liabilities $22M
Current Accounts Payable $2.6M
Deferred Revenue -
Current Debt -
Short Term Debt $3.5M
Total Non Current Liabilities $79M
Capital Lease Obligations $8.4M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $8.4M
Other Current Liabilities $16M
Other Non Current Liabilities $46K
Total Shareholder Equity -$29M
Treasury Stock -
Retained Earnings -$618M
Common Stock $8K
Common Stock Shares Outstanding $6.3M

ALGS News

ALGS Profile

Aligos Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Aligos Therapeutics, Inc. (ALGS) is an innovative clinical-stage biopharmaceutical company headquartered in South San Francisco, California, specializing in the development of groundbreaking therapies for viral infections and liver diseases. With a robust pipeline targeting chronic hepatitis B and liver fibrosis, Aligos is dedicated to addressing significant unmet medical needs through cutting-edge scientific research and strategic partnerships. The company's commitment to advancing transformative healthcare solutions, combined with its strong focus on high-impact therapeutic areas, makes it an attractive investment prospect for institutional investors seeking growth opportunities in the biopharmaceutical landscape.

LPTX
+368.57%
$2.05
WOK
-40.00%
$0.06
MASK
+36.34%
$0.41
OCG
-21.36%
$0.17
NVDA
+0.72%
$176.29
YGMZ
-61.42%
$0.02
TSLA
+3.56%
$475.31
ASST
-8.57%
$0.78
PAVS
-11.67%
$0.03
CGC
-4.59%
$1.66
IRBT
-72.68%
$1.18
ONDS
-12.11%
$7.69
IVP
+13.54%
$0.05
AMCI
+168.26%
$7.27
PLUG
-4.31%
$2.22
AAL
+2.47%
$15.33
MIST
-2.69%
$2.34
AXDX
-61.36%
$0.03
YCBD
0.00%
$1.20
ASBP
+13.05%
$0.10
AVGO
-5.59%
$339.81
RIVN
+1.52%
$18.70
INTC
-0.79%
$37.51
BMNR
-11.21%
$30.95
PFE
+2.24%
$26.43
LAZR
-60.82%
$0.35
BITF
-7.66%
$2.53
BMNU
-22.40%
$6.44
GRAB
-2.52%
$5.02
BYND
-4.58%
$1.04
WBD
-0.90%
$29.71
F
-0.79%
$13.65
ADAP
-15.14%
$0.05
AAPL
-1.49%
$274.11
SOFI
-5.35%
$25.82
CIFR
-13.54%
$14.74
IREN
-11.58%
$35.48
AMZN
-1.61%
$222.54
KVUE
-0.69%
$17.21
ARTV
+90.90%
$6.30
CLSK
-15.07%
$11.91
MARA
-7.11%
$10.70
PLTD
+0.30%
$6.48
ORCL
-2.65%
$184.92
APLD
-17.51%
$22.98
DNN
-2.68%
$2.54
SOND
-23.45%
$0.12
SNAP
-0.68%
$7.26
BTG
+0.43%
$4.62
TLRY
-10.04%
$10.93
NFLX
-1.49%
$93.77
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
T
-1.09%
$24.31
WULF
-12.84%
$12.49
ACHR
-5.66%
$7.83
HPE
+0.75%
$24.05
BTBT
-8.00%
$2.07
SRM
+53.27%
$10.30
VZ
-0.22%
$40.80
RGTI
-8.93%
$23.53
RKLB
-9.88%
$55.41
BAC
+0.34%
$55.33
PLTR
-0.17%
$183.25
UBER
-3.81%
$81.86
BBD
+0.57%
$3.47
CRWV
-7.93%
$72.35
NIO
-0.79%
$4.99
RIG
-1.21%
$4.08
AMC
-7.07%
$1.97
PFSA
-19.86%
$0.12
QBTS
-9.04%
$23.74
DVLT
-7.24%
$1.28
GOOGL
-0.34%
$308.22
BURU
-1.12%
$0.20
HOOD
-3.54%
$115.26
SOUN
-7.38%
$10.79
MU
-1.50%
$237.50
CAN
-6.13%
$0.78
AMD
-1.51%
$207.58
ATPC
-9.94%
$0.12
PCG
+1.31%
$15.36
RR
-14.56%
$3.52
MSTR
-8.14%
$162.08
HBAN
-0.44%
$17.74
TWOH
0.00%
$0.00
VIVK
-15.68%
$0.06
IMG
+6.17%
$1.72
MSFT
-0.77%
$474.82
AFMD
-34.94%
$0.18
CPNG
-5.07%
$24.33
URG
+3.90%
$1.33
TE
-5.42%
$5.06
CMG
-0.55%
$35.94
VALE
+0.63%
$12.77
CLYM
+27.00%
$3.81
IONQ
-8.50%
$46.07
CHR
-7.28%
$0.03
NCLH
+3.78%
$21.65
LPTX
+368.57%
$2.05
WOK
-40.00%
$0.06
MASK
+36.34%
$0.41
OCG
-21.36%
$0.17
NVDA
+0.72%
$176.29
YGMZ
-61.42%
$0.02
TSLA
+3.56%
$475.31
ASST
-8.57%
$0.78
PAVS
-11.67%
$0.03
CGC
-4.59%
$1.66
IRBT
-72.68%
$1.18
ONDS
-12.11%
$7.69
IVP
+13.54%
$0.05
AMCI
+168.26%
$7.27
PLUG
-4.31%
$2.22
AAL
+2.47%
$15.33
MIST
-2.69%
$2.34
AXDX
-61.36%
$0.03
YCBD
0.00%
$1.20
ASBP
+13.05%
$0.10
AVGO
-5.59%
$339.81
RIVN
+1.52%
$18.70
INTC
-0.79%
$37.51
BMNR
-11.21%
$30.95
PFE
+2.24%
$26.43
LAZR
-60.82%
$0.35
BITF
-7.66%
$2.53
BMNU
-22.40%
$6.44
GRAB
-2.52%
$5.02
BYND
-4.58%
$1.04
WBD
-0.90%
$29.71
F
-0.79%
$13.65
ADAP
-15.14%
$0.05
AAPL
-1.49%
$274.11
SOFI
-5.35%
$25.82
CIFR
-13.54%
$14.74
IREN
-11.58%
$35.48
AMZN
-1.61%
$222.54
KVUE
-0.69%
$17.21
ARTV
+90.90%
$6.30
CLSK
-15.07%
$11.91
MARA
-7.11%
$10.70
PLTD
+0.30%
$6.48
ORCL
-2.65%
$184.92
APLD
-17.51%
$22.98
DNN
-2.68%
$2.54
SOND
-23.45%
$0.12
SNAP
-0.68%
$7.26
BTG
+0.43%
$4.62
TLRY
-10.04%
$10.93
NFLX
-1.49%
$93.77
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
T
-1.09%
$24.31
WULF
-12.84%
$12.49
ACHR
-5.66%
$7.83
HPE
+0.75%
$24.05
BTBT
-8.00%
$2.07
SRM
+53.27%
$10.30
VZ
-0.22%
$40.80
RGTI
-8.93%
$23.53
RKLB
-9.88%
$55.41
BAC
+0.34%
$55.33
PLTR
-0.17%
$183.25
UBER
-3.81%
$81.86
BBD
+0.57%
$3.47
CRWV
-7.93%
$72.35
NIO
-0.79%
$4.99
RIG
-1.21%
$4.08
AMC
-7.07%
$1.97
PFSA
-19.86%
$0.12
QBTS
-9.04%
$23.74
DVLT
-7.24%
$1.28
GOOGL
-0.34%
$308.22
BURU
-1.12%
$0.20
HOOD
-3.54%
$115.26
SOUN
-7.38%
$10.79
MU
-1.50%
$237.50
CAN
-6.13%
$0.78
AMD
-1.51%
$207.58
ATPC
-9.94%
$0.12
PCG
+1.31%
$15.36
RR
-14.56%
$3.52
MSTR
-8.14%
$162.08
HBAN
-0.44%
$17.74
TWOH
0.00%
$0.00
VIVK
-15.68%
$0.06
IMG
+6.17%
$1.72
MSFT
-0.77%
$474.82
AFMD
-34.94%
$0.18
CPNG
-5.07%
$24.33
URG
+3.90%
$1.33
TE
-5.42%
$5.06
CMG
-0.55%
$35.94
VALE
+0.63%
$12.77
CLYM
+27.00%
$3.81
IONQ
-8.50%
$46.07
CHR
-7.28%
$0.03
NCLH
+3.78%
$21.65

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.